Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trialLudwig Kappos, Paul D. Crowe, Giancarlo Comi et al.|Nature Medicine|2000Cited by 515
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MSSarah L. Minden, Pushpa Narayanaswami, David C. Mohr et al.|Neurology|2013Cited by 235